Litcius/Paper detail

Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?

Bruno Vergès, Elise Pignol, Alexia Rouland, Benjamin Bouillet, S. Baillot-Rudoni, Emilienne Quilot, Abdelmadjid Djeffal, Jean Michel Petit

2021Journal of Diabetes Science and Technology18 citationsDOIOpen Access PDF

Abstract

Mean amplitude of glucose excursion (MAGE) is considered as the "gold standard" for assessing the short-term within-day glycemic variability (GV), which is an important component of overall glycemic control. A 14-day continuous glucose monitoring system is now widely used and allows easier assessment of GV. However, it is still unknown whether MAGE, usually calculated on a 48-hour period is identical whatever the time during the 14-day lifespan of the sensor and whether a longer time period might give additional information. We evaluated in 68 patients with type 1 diabetes, MAGE during three 2-day periods (day1-day3; day6-day8; day11-day13) and during periods of 3 days and 4 days. MAGE calculated at the three 2-day periods were identical and not different from MAGE of the 3-day or 4-day periods.

Topics & Concepts

GlycemicContinuous glucose monitoringExcursionMedicineReliability (semiconductor)Type 1 diabetesCoefficient of variationDiabetes mellitusDay to dayInternal medicineStatisticsEndocrinologyMathematicsOperations managementPhysicsPower (physics)Political scienceEconomicsQuantum mechanicsLawDiabetes Management and ResearchDiabetes Treatment and ManagementPancreatic function and diabetes
Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability? | Litcius